What are Zyn nicotine pouches and are they safe?

August 9, 2026 - 02:51

The U.S. Food and Drug Administration has granted marketing authorization to a line of Zyn nicotine pouches, a move that lets the company tell consumers the products are a better choice than smoking in certain respects. This is the first time the agency has allowed a nicotine pouch maker to use language suggesting a modified risk, meaning the product can be marketed as reducing exposure to some harmful chemicals found in cigarette smoke.

Zyn pouches are small, white sachets placed between the gum and lip. They contain nicotine but no tobacco leaf, and users do not inhale anything. The FDA decision applies to 10 Zyn varieties, including popular flavors like cool mint and wintergreen, all with nicotine strengths of 3 or 6 milligrams. The agency reviewed data showing that switching completely from cigarettes to these pouches lowers levels of certain cancer-causing substances in the body, such as tobacco-specific nitrosamines.

Still, the authorization is not a clean bill of health. The FDA stressed that Zyn pouches are not safe for young people, pregnant women, or non-smokers. Nicotine is highly addictive, and the agency noted that the products still carry health risks, including potential harm to the developing brain. The decision also comes with strict advertising rules. Zyn cannot claim the pouches help people quit smoking, and the company must run a post-market study to track how the products are used and perceived.

Public health experts are split. Some see the move as a practical step for adults who cannot quit nicotine, while others worry that "reduced harm" messaging could lure teenagers into using a product that is not risk-free. The FDA says it will monitor the market closely and can pull the authorization if the company fails to meet safety or marketing requirements.